Hi [[ session.user.profile.firstName ]]

Development of Cell-Based Assays to Test Compound Responses

This webinar will provide an overview of the important optimization steps to be taken into consideration when developing a cell-based assay to test the effects of chemical compounds. Consideration will be given to assay formats ranging from single molecule evaluations all the way through to high-thr
This webinar will provide an overview of the important optimization steps to be taken into consideration when developing a cell-based assay to test the effects of chemical compounds. Consideration will be given to assay formats ranging from single molecule evaluations all the way through to high-throughput screening of libraries comprising a million compounds or more. The material is intended to serve as an introduction to cell-based assays, and is intended for those with little or no experience in the field.

Topics to be covered include: considerations when choosing a model cell line; understanding optimal cell culture conditions; use of fresh vs. cryopreserved cells; importance of the microplate in cell-based assays; overview of assay formats covering traditional "label-dependent" and newer label-free assays.
Recorded Dec 7 2010 50 mins
Your place is confirmed,
we'll send you email reminders
Presented by
David Randle, Ph.D.
Presentation preview: Development of Cell-Based Assays to Test Compound Responses
Recommended for you:
  • Date
  • Rating
  • Views
  • When Bad Things Happen to Good Data: Plan For and Achieve Business Continuity When Bad Things Happen to Good Data: Plan For and Achieve Business Continuity Jon Toigo, Chairman, Data Management Institute Recorded: Apr 27 2016 48 mins
    High Availability doesn’t trump Disaster Recovery and there is nothing simple about creating a recovery capability for your business – unless you have a set of data protection and business continuity services that can be applied intelligently to your workload, managed centrally, and tested non-disruptively. The good news is that developing such a capability, which traditionally required the challenge of selecting among multiple point product solutions then struggling to fit them into a coherent disaster prevention and recovery framework, just got a lot easier.

    Join us and learn how DataCore’s Software-Defined Storage platform provides the tools you need and a service management methodology you require to build a fully functional recovery strategy at a cost you can afford.
  • Disrupting and improving customer engagement with predictive insights Disrupting and improving customer engagement with predictive insights David Davidovic, Jerome Mead, Leilani Latimer, Paul Tunnah Recorded: Apr 27 2016 63 mins
    There are clear benefits for both Life Sciences companies and their customers in significantly improving the way they engage. Be it in terms of reputation, efficiency, profitability, or even relationship quality and longevity, engagement has and will always be the key to successful business practice.

    Recent exclusive research conducted in conjunction with Zephyr Health revealed that both frontline sales forces and sales management professionals want to improve engagement strategies with new technology utilizing predictive insights. However, despite having new tools available to them, sales teams remain heavily reliant on the same techniques that were being used decades ago.

    So what is the answer – how do life sciences companies disrupt this pattern and make significant strides to improve engagement?

    Working with Zephyr Health, we present an expert webinar that will answer this very question, bringing together industry experts to discuss why the disruption is critical, how it can be achieved, and the core role that predictive insights play in this process.

    As with all of our webcasts, this is an interactive debate designed to enable you to get the answers you need.

    Topics covered include:

    •Customer engagement challenges and trends: the need for disruptive customer engagement – what the survey revealed
    •The challenges facing Life Sciences customer engagement
    •Why technology is only partially solving the problem
    •The evolution of CRM: from historic analytics to current analytics to future analytics – knowing what your customer wants before they do
    •Overcoming internal blockers to change within Life Sciences – the roadmap for success
  • e-Medical excellence at launch e-Medical excellence at launch Fonny Schenck (CEO, Across Health) and Ben Harbour (MD, Across Health UK) Recorded: Apr 26 2016 60 mins
    This webinar will provide you with an overview how digital can be integrated into medical plans and what it takes to deliver multichannel medical excellence at launch.

    Key topics include:
    •Overview of typical launch categories and their key communication drivers and multichannel opportunities
    •The 4 main pre-launch stakeholders and how to integrate digital initiatives in a balanced medical mix whilst respecting legal and regulatory guidelines
    oeKOLs: Gathering insight and engagement planning
    oeHCPs: Channel selection to ensure immersive learning and education
    oePatients: Gathering treatment insight and prepare education & value-focused “beyond the-pill” strategies for launch
    oePayers: Establish value
    •Assess the clinical impact of e-medical programmes and how to create KPIs and dashboards to assess the success of your cross-channel activities
    •Prepare your organization for emedical excellence through multichannel skills development and enablement for MSLs and internal staff
  • The Creative Debate: Why creativity is key to true patient centricity in pharma The Creative Debate: Why creativity is key to true patient centricity in pharma Kai Gait, Maneesh Juneja, Lions Health jury member, Paul Tunnah Recorded: Apr 26 2016 66 mins
    Meeting the needs of both patients, and healthcare professionals, in today's fast changing communications landscape can be challenging, particularly against the backdrop of compliance. Putting creativity at the heart of the process can be the most effective way of tackling these challenges.

    Although the return on investment of creativity is not always easy to measure, the value it can bring to pharma and healthcare is increasingly evident.

    This webinar brings together a wealth of expertise to deliver case-study based evidence, interactive debate and practical advice on deriving competitive advantage from the creative process and ensuring patients are truly at the heart of your business.
  • Specialized Applications Using the Corning® Spheroid Microplate Specialized Applications Using the Corning® Spheroid Microplate Hilary Sherman, Applications Specialist & Audrey Bergeron, Application Specialist Recorded: Apr 22 2016 47 mins
    Three-dimensional (3D) cell culture models, which offer significant improvements over traditional two dimensional monolayer cell culture in terms of maintaining morphological and functional characteristics of tissue, are increasingly being incorporated in drug discovery as model systems to study disease or for screening for chemotherapeutic efficacy or drug toxicity. This presentation will demonstrate the use of Corning® spheroid microplates to culture and assay spheroids in a rapid and highly reproducible format that enables the formation of a single multi-cellular spheroid, centered in each well.

    Corning spheroid microplates are multiple well, cell culture plates with opaque walls and unique clear, round well-bottom geometry that utilize the Corning Ultra-Low Attachment surface coating. The coating is hydrophilic, biologically inert and non-degradable. Representative data will be shown exhibiting the use of the spheroid microplate in more specialized assays including the formation of neurospheres from neural stem cells (NSCs), a valuable model to study neurogenesis and neural development, as well as analysis of NSC proliferation and migration. We will also demonstrate the formation of hepatospheres using Corning HepatoCells, an immortalized alternative to primary human hepatocytes, in combination with the SCREEN-WELL Hepatotoxicity library from Enzo Life Sciences for 3D hepatotoxicity screening. Finally, we will show the use of the Corning spheroid microplate to generate spheroids comprised of multiple cell types, demonstrating the impact that including multiple cell types in 3D assays can have on therapeutic outcome in a chemotherapeutic assay.
  • Optimize Your Germ-Zapping Robot: Best practices & review of published studies Optimize Your Germ-Zapping Robot: Best practices & review of published studies Founder Dr. Mark Stibich, PhD Recorded: Apr 21 2016 60 mins
    PASSWORD: LightStrike -- Join this webinar to become an instant expert in xenon light room disinfection. Hear the latest evidence-based best practices for optimizing the use of Xenex Germ-Zapping Robots to tackle C. diff, MRSA and other difficult pathogens that linger in hospitals and post-acute care units.

    Hospitals across the country continue to publish infection rate reductions achieved using pulsed xenon light disinfection technology. Dr. Mark Stibich, Xenex Founder and Chief Scientific Officer, will discuss the published outcome studies to date and share best practices to help you reduce the risk of infection in your facility.
  • Optimize Your Germ-Zapping Robot: Best practices & review of published studies Optimize Your Germ-Zapping Robot: Best practices & review of published studies Founder Dr. Mark Stibich, PhD Recorded: Apr 20 2016 63 mins
    PASSWORD: LightStrike -- Join this webinar to become an instant expert in xenon light room disinfection. Hear the latest evidence-based best practices for optimizing the use of Xenex Germ-Zapping Robots to tackle C. diff, MRSA and other difficult pathogens that linger in hospitals and post-acute care units.

    Hospitals across the country continue to publish infection rate reductions achieved using pulsed xenon light disinfection technology. Dr. Mark Stibich, Xenex Founder and Chief Scientific Officer, will discuss the published outcome studies to date and share best practices to help you reduce the risk of infection in your facility.
  • LEAN High-Volume Hematology Solutions LEAN High-Volume Hematology Solutions Alan Neal, CSci, MSc, FIBMS, quality manager and lead of specialty, hematology, at Pathology Associates Recorded: Apr 19 2016 65 mins
    Learn how Beckman Coulter’s hematology and laboratory automation technologies have helped standardize procedures, deliver consistent turnaround time, reduce manual intervention, and achieve high auto validation rates. Alan Neal will share how his laboratory implemented Beckman Coulter automation and LEAN manufacturing principles.
  • A Day Inside a Security Operations Center A Day Inside a Security Operations Center Joe Schreiber & Garrett Gross Recorded: Apr 19 2016 61 mins
    SOCs, or Security Operations Centers,; You’ve seen them in the news, the movies, even on TV. But what really happens on the inside? What are they showing on those screens when the cameras aren’t rolling? If you think it’s all about the screens and even more screens you only know half the story. In this webinar you’ll get to know what SOC analysts actually do on a daily basis when they aren’t browsing Reddit or cursing the existence of Flash.
    Join this webinar to learn:
    What happens in a SOC on a typical day, when there aren’t “incidents”
    Roles, responsibilities and skillsets of successful SOC teams
    Why teamwork is essential to a SOC
    We'll finish up with a demo of AlienVault USM to show how it can help SOC analysts speed up threat detection and incident response.
  • The Only Constant is Change – GDPR and Data Privacy The Only Constant is Change – GDPR and Data Privacy Ted Sherrill, Oracle; Graham Jackson, (ISC)2; Harvey Nusz, 4IT Security Recorded: Apr 14 2016 59 mins
    The General Data Protection Regulation (GDPR) is being instituted to improve data protection and privacy for individuals in the European Union (EU). Additionally, it addresses the export of data outside the EU, which will impact all multi-national businesses operating in the EU. Almost 3/4 of US Privacy professional believe that this is the most significate change to privacy regulations in the last 20 years. What should an organization be doing now to prepare for this new regulation to avoid non-compliance, fines and increased spending? Join Oracle and (ISC)2 on April 14, 2016 at 1:00PM Eastern for a discussion on this new regulation and how your organization could be impacted.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Development of Cell-Based Assays to Test Compound Responses
  • Live at: Dec 7 2010 7:55 pm
  • Presented by: David Randle, Ph.D.
  • From:
Your email has been sent.
or close
You must be logged in to email this